Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 801
Aptamer sequence: CTCTCGGGACGACGGCCCGATCTCAGAGTAGTCGTCCC
Target unique ID: 6057
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_722 Tyrosine-Cp*Rh(III) sensor Molecule Tyrosine 2.9 nM 100 μM concentration of monomeric Cp*Rh(III) 25343606
Structure information of aptamer
Aptamer Sequence: CTCTCGGGACGACGGCCCGATCTCAGAGTAGTCGTCCC
The optimal secondary structure in dot-bracket notation: .....((((((((.((...........)).))))))))
The centroid secondary structure in dot-bracket notation: .....((((((((.((...........)).))))))))
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_722 Description Tyrosine-Cp*Rh(III) sensor
Aptamer chemistry DNA Length 38 nt
GC content 65.8% Molecular weight 11,616.44 Da
Molarity of 1 μg/μl solution 86.08 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Aptasensor
Sequence CTCTCGGGACGACGGCCCGATCTCAGAGTAGTCGTCCC
Applications Binding to amino acids
Target information
Type Detail Type Detail
PubChem ID 6057 Molecular name Tyrosine
Molecular formula C9H11NO3 Molecular weight 181.19
IUPAC name (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid InChIKey OUYCCCASQSFEME-QMMMGPOBSA-N
LogP 0.347 Topological polar surface area 83.55
Hydrogen bond acceptor 3 Hydrogen bond donor 3

Synonym(s):
L-tyrosine; tyrosine; 60-18-4; (S)-Tyrosine; p-Tyrosine; L-p-Tyrosine; H-Tyr-OH; (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid; 4-Hydroxy-L-phenylalanine; L-(-)-Tyrosine; Tyrosinum [Latin]; Tyrosine (VAN); Tirosina [Spanish]; (-)-alpha-Amino-p-hydroxyhydrocinnamic acid; L-Phenylalanine, 4-hydroxy-; beta-(p-Hydroxyphenyl)alanine; Tyrosine [USAN:INN]; Tyrosine, L-; (S)-alpha-Amino-4-hydroxybenzenepropanoic acid; 3-(4-Hydroxyphenyl)-L-alanine; FEMA No. 3736; L-2-Amino-3-p-hydroxyphenylpropanoic acid; (S)-3-(p-Hydroxyphenyl)alanine; (S)-(-)-Tyrosine; HSDB 2003; alpha-Amino-beta-(4-hydroxyphenyl)propionic acid; AI3-09055; tirosina; Propanoic acid, 2-amino-3-(4-hydroxyphenyl)-, (S)-; NSC 82624; L-tyrosinyl radical; alpha-Amino-p-hydroxyhydrocinnamic acid, (-)-; L-Tyr; (S)-2-Amino-3-(4-hydroxyphenyl)propanoic acid; (S)-2-Amino-3-(p-hydroxyphenyl)propionic acid; L-Tyrosine, monomer; alpha-Amino-4-hydroxybenzenepropanoic acid, (S)-; UNII-42HK56048U; Benzenepropanoic acid, alpha-amino-4-hydroxy-, (S)-; MFCD00002606; (S)-2-Amino-3-(4-hydroxyphenyl)propionic acid; 2-Amino-3-(4-hydroxyphenyl)propanoic acid, (S)-; tyr; CHEBI:17895; 42HK56048U; NCGC00159350-02; Tyrosine (L-Tyrosine); Tyrosinum; DSSTox_CID_3730; L-Tyrosin; DSSTox_RID_77170; DSSTox_GSID_23730; L-Tyrosine, homopolymer; CAS-60-18-4; L-Tyrosine (9CI); 4ts1; Tyrosine (USP/INN); EINECS 200-460-4; plovamer-acetate; Benzenepropanoate; NSC-82624; 2csm; (L)-Tyrosine; (-) tyrosine; 25619-78-7; H-Tyr; L-Tyrosine,(S); (-)-.alpha.-Amino-p-hydroxyhydrocinnamic acid; L-Tyrosine (JP17); Tyrosine, L- (8CI); .alpha.-Amino-.beta.-(4-hydroxyphenyl)propionic acid; Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs; bmse000051; CHEMBL925; SCHEMBL1581; L-[U-14C]Tyr; L-Phenylalanine-4-hydroxy-; L-Tyrosine non-animal source; Levodopa impurity, l-tyrosine-; GTPL4791; L-Tyrosine, >=97%, FG; DD69927C-C6A8-4BC6-8E9A-0AB423B176E7; DTXSID1023730; BDBM18129; L-Tyrosine, Cell Culture Reagent; ZINC266964; N-acetyl-o-(dihydroxymethylsilyl)-; HY-N0473; L-Tyrosine, Vetec(TM), 98.5%; Levodopa related compound l-tyrosine; Tox21_111594; (-)-a-Amino-p-hydroxyhydrocinnamate; AC2634; s4608; AKOS010400205; Tox21_111594_1; (S)-a-Amino-4-hydroxybenzenepropanoate; AM82304; CS-8013; DB00135; MCULE-2932088896; (-)-alpha-Amino-p-hydroxyhydrocinnamate; (-)-a-Amino-p-hydroxyhydrocinnamic acid; (S)-a-amino-4-hydroxy-Benzenepropanoate; NCGC00159350-03; NCGC00344525-01; AC-11295; AS-11772; BP-13285; Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs, oxidized with hydrogen peroxide; Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs, oxidized with hydrogen peroxide, <3 kd fraction; Melanin synthesized from Tyr substrate catalyzed by tyrosinase, brominated with N-bromosuccinimide; Melanin synthesized from Tyr substrate catalyzed by tyrosinase, sulfonated using sulfur trioxide/DMF complex for 1.5-7 hours; (S)-alpha-Amino-4-hydroxybenzenepropanoate; DIETHYL1,3,5-BENZENETRICARBOXYLATE; L-Tyrosine, BioUltra, >=99.0% (NT); (S)-2-Amino-3-(p-hydroxyphenyl)propionate; (S)-a-Amino-4-hydroxybenzenepropanoic acid; AB0010718; DB-029987; L-Tyrosine, Free Base - CAS 60-18-4; (S)-a-amino-4-hydroxy-Benzenepropanoic acid; (S)-alpha-amino-4-hydroxy-Benzenepropanoate; L-Tyrosine, reagent grade, >=98% (HPLC); L-Tyrosine, SAJ special grade, >=99.0%; T0550; Y9454; C00082; D00022; D70837; L-Tyrosine, Vetec(TM) reagent grade, >=98%; M02963; (2S)-2-amino-3-(4-hydroxyphenyl)propanoicacid; (S)-alpha-amino-4-hydroxy-Benzenepropanoic acid; 88844-EP2289892A1; 88844-EP2305825A1; (S)-.alpha.-Amino-4-hydroxybenzenepropanoic acid; 002T606; 2-Amino-3-(4-hydroxyphenyl)propanoic acid-(S)-; A832631; Q188017; J-521656; Propanoic acid, 2-amino-3-(4-hydroxyphenyl)-(S)-; Q27115106; Benzenepropanoic acid, .alpha.-amino-4-hydroxy-, (S)-; F8889-8713; L-Tyrosine, certified reference material, TraceCERT(R); Tyrosine, European Pharmacopoeia (EP) Reference Standard; Z1250208672; UNII-0O72R8RF8A component OUYCCCASQSFEME-QMMMGPOBSA-N; UNII-A9BAT9B32M component OUYCCCASQSFEME-QMMMGPOBSA-N; UNII-N7U7BXP2OI component OUYCCCASQSFEME-QMMMGPOBSA-N; L-Tyrosine, United States Pharmacopeia (USP) Reference Standard; 2-amino-3-(4-hydroxyphen yl)-2-amino-3-(4-hydroxyphenyl)-Propanoate; 2-amino-3-(4-hydroxyphen yl)-2-amino-3-(4-hydroxyphenyl)-Propanoic acid; Benzeneethanaminium, a-carboxy-4-hydroxy-N,N,N-trimethyl-,inner salt, (aS)-; 1189756-47-5; L-Tyrosine, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, >=99.0%; L-Tyrosine, PharmaGrade, Ajinomoto, EP, JP, USP, manufactured under appropriate GMP controls for pharma or biopharmaceutical production, suitable for cell culture

Activity data
Interaction ID 801
Target type Molecule
Target unique ID 6057
Activity 2.9 nM
Binding Conditions/Buffer

100 μM concentration of monomeric Cp*Rh(III)

Assay

The response of sensors IV–VI at low concentrations of amino acids, representative for measurements in diluted blood or serum

PubMed ID 25343606
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_593 DNA CTCTCGGGACGACAGCCGAGTTGATTCAACAGCCGAGTCGTCCC 72.73%
Apta_697 DNA CTCTCGGGACGACGGACGCTAATCTTACAAGGGCGTAGTGTATGTCGTCCC 70.59%
Apta_591 DNA CTCTCGGGACGACGGCTGGCACGTTTGGTTCAAGAATGTGGGTGTCGTCCC 68.63%
Apta_592 DNA CTCTCGGGACGACCACTACGCATAGTTTCTATCGCCAGGAAGGGTCGTCCC 64.71%
Apta_721 DNA CTCTCGGGACGACCGCGGTAGTCTTAACCTAAAGCGGTGTCAGGTCGTCCC 64.71%
Apta_556 DNA GGCTCTCGGGACGACATGGATTTTCCATCAACGAAGTGCGTCCGTCCC 64.58%
Apta_362 DNA GGGAACGCACCGATCGCAGGTTTCCC 60.53%
Apta_960 DNA CCCGAGGCACGAGGGGGAACGTATCGTCATGTGCCGGCCA 57.50%
Apta_835 DNA TATGGCGTGGCAAGCTTGGCCCGCTTCTCAAGCATGGTTATCTAC 55.56%
Apta_358 DNA GGGAATCGCCACCCGACGCAGGGTTTCCC 55.26%
Apta_1067 DNA GCGCGGTACCGCGCTAACGGAGGTTGCGTCCGT 55.26%
Apta_1199 DNA CCCTGCGGGGCTGCCCGATATGTGTCCAAGTGGTG 55.26%
Apta_1199 DNA CCCTGCGGGGCTGCCCGATATGTGTCCAAGTGGTG 55.26%
Apta_1199 DNA CCCTGCGGGGCTGCCCGATATGTGTCCAAGTGGTG 55.26%
Apta_1199 DNA CCCTGCGGGGCTGCCCGATATGTGTCCAAGTGGTG 55.26%
Apta_1208 DNA CCCTGCGGGGCTGCCCGATATGTGTCCAGGTGGTG 55.26%
Apta_344 DNA CACTACAGAGGTTGCGTCTGTCCCACGTTGTCATGGGGGGTTGGCCTG 54.17%
Apta_1023 DNA CTCCTTCAACGAAGTGGGTCTCCTTCAACGAAGTGGGTCTC 53.66%
Apta_449 DNA CGCACTATGTTTTACGAGCCGTTTCCTCGGCAGATAGTAAGTGCG 53.33%
Apta_636 DNA TAGCCGGATCGCGCTGGCCAGATGATATAAAGGGTCAGCCCCCCA 53.33%